Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
BBI Solutions
BBI Solutions
Activities:
Ingredients
Analysis
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Ingredients
BBI Solutions completes reagent manufacturer acquisition
BioTeZ is a manufacturer of reagents and finished tests for the in-vitro diagnostics (IVD) market
Finance
BBI creates new jobs to support next phase in COVID-19 home test development
The lateral flow antibody test that can be used by people in their homes to determine if they have an antibody response to COVID-19
Research & Development
BBI Solutions partners to distribute COVID-19 antigens in China
The Native Antigen Company has agreed distribution rights with BBI to provide coronavirus reagents in China
Ingredients
BBI Solutions expands infectious disease reagent suite
BBI Solutions has demonstrated internal antibody development capabilities and has also expanded its infectious disease reagent suite
BBI Solutions increases capacity for transferrin production
BBI Solutions (BBI) has invested in its facilities and resources to increase the capacity of cell culture native human transferrin production by up to 40%
Subscribe now